Related Experiment Video
Updated: Apr 29, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Changing clinical patterns and increasing prevalence in CADASIL
F C Moreton1, S S M Razvi, R Davidson
1Institute of Neuroscience and Psychology, University of Glasgow, Southern General Hospital, Glasgow, UK.
Insights
Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) affects at least 4.6 per 100,000 adults. This study reveals a potentially later age of first stroke and highlights the importance of considering CADASIL in older stroke patients.
Area of Science:
- Neurology
- Genetics
- Vascular Biology
Background:
- Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic small vessel disease leading to recurrent strokes.
- Phenotypic variability exists, with early descriptions suggesting dementia and disability onset in the fifth decade.
Purpose of the Study:
- To determine the prevalence and clinical characteristics of CADASIL in the west of Scotland.
- To investigate the impact of diagnostic timing on clinical outcomes.
Main Methods:
- Retrospective review of clinical records from a specialist CADASIL clinic.
- Analysis of NOTCH3 mutations and pedigree data to estimate prevalence.
- Stratification of patients by age and date of diagnosis to assess clinical outcomes.
Main Results:
- Identified 49 pedigrees with 21 different NOTCH3 mutations, predominantly in exon 4.
- Established a disease prevalence of 4.6 per 100,000 adults in Glasgow.
- Observed a median age of first stroke in women of 57 years, and a later age of stroke onset in men diagnosed more recently (56 years vs. 46 years).
- Found that 38% of patients over 58 were living independently and 61% were mobile without aids.
Conclusions:
- CADASIL prevalence is at least 4.6 per 100,000 adults, with mutation prevalence at 10.7 per 100,000.
- The median age of first stroke may be later than previously reported.
- CADASIL should be considered in the differential diagnosis of stroke, even in older individuals.
Objectives:
CADASIL is a monogenic small vessel vasculopathy causing recurrent stroke. Early descriptions suggested dementia and disability were common from the 5th decade but there is evidence of marked phenotypic variability. We investigated the prevalence and clinical features of CADASIL in the west of Scotland.
Methods:
We undertook a retrospective review of clinical records of patients with confirmed CADASIL identified through a specialist clinic. Patients were divided to examine the effect of date of diagnosis on clinical outcomes and the characteristics at different ages. The location of pedigree members was used to estimate prevalence.
Results:
Twenty-one different CADASIL-causing NOTCH3 mutations were identified in 49 pedigrees (61% in exon 4). Disease prevalence in Glasgow was 4.6/100,000 adults. Mutation prevalence was estimated at 10.7/100,000 population. Median age at first stroke in women (57 years) was higher than previous estimates, and stroke age in men was higher in patients diagnosed more recently (pre 2006 46 years, post 2006 56 years, P=0.034). In patients over 58 years of age, 13/34 (38%) were living independently and 17/28 (61%) were mobile without aids when last seen.
Conclusions:
CADASIL prevalence is at least 4.6 per 100,000 adults. Median age of first stroke may be older than previously thought. Clinicians should consider CADASIL in the differential diagnosis even in older patients with stroke.
More Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Encephalitis l: Introduction
Multiple Sclerosis l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cerebral Edema ll: Pathophysiology